Here, we report for the first time that triplication of chromosome 21 genes other than APP, increases amyloid-β aggregation, plaque formation, and cognitive deficits in a novel Down syndrome–Alzheimer’s disease (amyloid-β deposition) mouse model. This evidence concerns the gene APP and Down syndrome.